Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 17.84
+0.39 (2.23%)
At close: Aug 4, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 1.92 billion as of August 4, 2026. Its market cap has decreased by -26.59% in one year.
Market Cap
1.92B
Enterprise Value
1.21B
Revenue
209.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.84
ChartMarket Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 1.92B, a decrease of -52.79%. That is a compound annual growth rate of -18.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.92B | -26.77% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 2.47B |
| Novoprotein Scientific | 2.45B |
| Shandong Sito Bio-technology | 2.25B |
| Jilin Jian Yisheng Pharmaceutical | 2.14B |
| Shanghai Universal Biotech | 2.14B |
| Suzhou Fushilai Pharmaceutical | 2.07B |
| Shanghai Hile Bio-Technology | 1.86B |
| Guiyang Xintian Pharmaceutical | 1.81B |